An adjusted ELISpot-based immunoassay for evaluation of SARS-CoV-2-specific T-cell responses

Like antibody evaluation, using an effective antigen-specific T-cell immunity assessment method in coronavirus disease 2019 (COVID-19) patients, survivors and vaccinees is crucial for understanding the immune persistence, prognosis assessment, and vaccine development for COVID-19. This study evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hao, Zhang, Jie, Dong, Shaobo, Liu, Yaning, Liu, Peipei, Gao, George F., Liu, William J., Wu, Guizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022 Chinese Medical Association Publishing House. Published by Elsevier BV. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047432/
https://www.ncbi.nlm.nih.gov/pubmed/35505811
http://dx.doi.org/10.1016/j.bsheal.2022.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047432/
https://www.ncbi.nlm.nih.gov/pubmed/35505811
http://dx.doi.org/10.1016/j.bsheal.2022.04.005

Ejemplares similares